公司新闻
浙江杭州及美国消息（2024年12月3日）-杭州新元素药业有限公司（以下简称“新元素药业”，曾用名“江苏新元素医药科技有限公司”）是一家致力于治疗代谢和抗炎领域疾病的创新药物研发企业，今天公布新元素药业与康哲药业控股有限公司（以下简称“康哲药业”）附属公司就治疗痛风及高尿酸血症的1类新药ABP-671...
2024年4月16日，杭州新元素药业有限公司（新元素药业，Atom Therapeutics）是一家致力于治疗代谢和抗炎领域疾病的创新药物研发企业，今天宣布胡贤君先生自2024年4月16日起加入新元素药业，担任临床副总裁，他将全面负责中国临床事务。...
JANUARY 02, 2024 JIANGSU, China–January 2, 2024 –Atom Therapeutics (Hangzhou Atom Therapeutics Co.,...
OCTOBER 16, 2023 JIANGSU, China–October 16, 2023–Atom Therapeutics (Hangzhou Atom Therapeutics Co.,...
OCTOBER 9, 2023 JIANGSU, China–Atom Therapeutics (Hangzhou Atom Therapeutics Co., Ltd.), a clinical...
May 24, 2023 By: Ben Adams Atom Therapeutics wants people to see that gout is more that...
Gout Myths—Busted It’s more your genes and less your lifestyle, say our experts. Aug 11, 2022 ...
Published: Mar 21, 2022 Preliminary data suggest Atom’s compound reduces uric acid levels to prevent...
PRESS RELEASE Atom Therapeutics Marks Gout Awareness Day by Urging Increased Patient Education on Debilitating...
PRESS RELEASE Atom Therapeutics Names UC San Diego Professor Robert Terkeltaub, M.D., to its Scientific...
PRESS RELEASE Atom Therapeutics Announces Positive Results of Phase 2a China Clinical Trial of Its URAT1...
PRESS RELEASE Atom Therapeutics to Present at BIO CEO & Investor Conference on February 6, 2023,...
PRESS RELEASE Atom Therapeutics Names Stanford University Professor Vibeke Strand, M.D., to its Scientific...
PRESS RELEASE Atom Therapeutics to Present Final Data from its Positive Phase 2a Clinical Trial in Chronic...
PRESS RELEASE Atom Therapeutics Announces Abstract for Its Phase 2a Gout Study Accepted for American...
PRESS RELEASE Atom Therapeutics to Update Clinical Development of New Drug to Treat Gout at BIO International...
PRESS RELEASE On Gout Awareness Day, Let’s Put the Myths to Rest Genetic abnormalities are the real cause...
Gout is genetic disease with a surging patient population worldwide
Lead drug targets unmet medical need in chronic gout Provides significant serum uric acid reduction in...
Lead drug targets unmet medical need in chronic gout Provides significant efficacy without toxic side...
行业动态
At ABP-671 1mg doses given once daily, 86% of the subjects reached serum uric acid levels that were below...
US veterans with gout have an excess death risk that is largely attributable to comorbidities, particularly...
Arthritis & Rheumatology:Study Compares Gout Treatments with Different Mechanisms of Action – URAT1 Inhibitor vs Xanthine Oxidase Inhibitor
How Gout Flare-ups May Increase the Risk of Heart Attack, Stroke Gout is a type of arthritis caused by...